                         SEQUENCE LISTING

<110>  Array BioPharma Inc.
       Ellis, Bryan Daniel
       Hicken, Erik James
       Laird, Ellen Ruth
       Lazzara, Nicholas Charles
       Newhouse, Bradley Jon
       Pajk, Spencer Phillip
       Rosen, Rachel Zoe
       Shelp, Russell Andrew
 
<120>  HER2 MUTATION INHIBITORS

<130>  PC072760A

<150>  63/350,495
<151>  2022-06-09

<150>  63/294,590
<151>  2021-12-29

<150>  63/215,435
<151>  2021-06-26

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  604
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1

Met Ala His His His His His His His His Gly Gly Gly Gly Gly Leu 
1               5                   10                  15      


Val Pro Arg Gly Lys Arg Arg Gln Gln Lys Ile Arg Lys Tyr Thr Met 
            20                  25                  30          


Arg Arg Leu Leu Gln Glu Thr Glu Leu Val Glu Pro Leu Thr Pro Ser 
        35                  40                  45              


Gly Ala Met Pro Asn Gln Ala Gln Met Arg Ile Leu Lys Glu Thr Glu 
    50                  55                  60                  


Leu Arg Lys Val Lys Val Leu Gly Ser Gly Ala Phe Gly Thr Val Tyr 
65                  70                  75                  80  


Lys Gly Ile Trp Ile Pro Asp Gly Glu Asn Val Lys Ile Pro Val Ala 
                85                  90                  95      


Ile Lys Val Leu Arg Glu Asn Thr Ser Pro Lys Ala Asn Lys Glu Ile 
            100                 105                 110         


Leu Asp Glu Ala Tyr Val Met Ala Tyr Val Met Ala Gly Val Gly Ser 
        115                 120                 125             


Pro Tyr Val Ser Arg Leu Leu Gly Ile Cys Leu Thr Ser Thr Val Gln 
    130                 135                 140                 


Leu Val Thr Gln Leu Met Pro Tyr Gly Cys Leu Leu Asp His Val Arg 
145                 150                 155                 160 


Glu Asn Arg Gly Arg Leu Gly Ser Gln Asp Leu Leu Asn Trp Cys Met 
                165                 170                 175     


Gln Ile Ala Lys Gly Met Ser Tyr Leu Glu Asp Val Arg Leu Val His 
            180                 185                 190         


Arg Asp Leu Ala Ala Arg Asn Val Leu Val Lys Ser Pro Asn His Val 
        195                 200                 205             


Lys Ile Thr Asp Phe Gly Leu Ala Arg Leu Leu Asp Ile Asp Glu Thr 
    210                 215                 220                 


Glu Tyr His Ala Asp Gly Gly Lys Val Pro Ile Lys Trp Met Ala Leu 
225                 230                 235                 240 


Glu Ser Ile Leu Arg Arg Arg Phe Thr His Gln Ser Asp Val Trp Ser 
                245                 250                 255     


Tyr Gly Val Thr Val Trp Glu Leu Met Thr Phe Gly Ala Lys Pro Tyr 
            260                 265                 270         


Asp Gly Ile Pro Ala Arg Glu Ile Pro Asp Leu Leu Glu Lys Gly Glu 
        275                 280                 285             


Arg Leu Pro Gln Pro Pro Ile Cys Thr Ile Asp Val Tyr Met Ile Met 
    290                 295                 300                 


Val Lys Cys Trp Met Ile Asp Ser Glu Cys Arg Pro Arg Phe Arg Glu 
305                 310                 315                 320 


Leu Val Ser Glu Phe Ser Arg Met Ala Arg Asp Pro Gln Arg Phe Val 
                325                 330                 335     


Val Ile Gln Asn Glu Asp Leu Gly Pro Ala Ser Pro Leu Asp Ser Thr 
            340                 345                 350         


Phe Tyr Arg Ser Leu Leu Glu Asp Asp Asp Met Gly Asp Leu Val Asp 
        355                 360                 365             


Ala Glu Glu Tyr Leu Val Pro Gln Gln Gly Phe Phe Cys Pro Asp Pro 
    370                 375                 380                 


Ala Pro Gly Ala Gly Gly Met Val His His Arg His Arg Ser Ser Ser 
385                 390                 395                 400 


Thr Arg Ser Gly Gly Gly Asp Leu Thr Leu Gly Leu Glu Pro Ser Glu 
                405                 410                 415     


Glu Glu Ala Pro Arg Ser Pro Leu Ala Pro Ser Glu Gly Ala Gly Ser 
            420                 425                 430         


Asp Val Phe Asp Gly Asp Leu Gly Met Gly Ala Ala Lys Gly Leu Gln 
        435                 440                 445             


Ser Leu Pro Thr His Asp Pro Ser Pro Leu Gln Arg Tyr Ser Glu Asp 
    450                 455                 460                 


Pro Thr Val Pro Leu Pro Ser Glu Thr Asp Gly Tyr Val Ala Pro Leu 
465                 470                 475                 480 


Thr Cys Ser Pro Gln Pro Glu Tyr Val Asn Gln Pro Asp Val Arg Pro 
                485                 490                 495     


Gln Pro Pro Ser Pro Arg Glu Gly Pro Leu Pro Ala Ala Arg Pro Ala 
            500                 505                 510         


Gly Ala Thr Leu Glu Arg Ala Lys Thr Leu Ser Pro Gly Lys Asn Gly 
        515                 520                 525             


Val Val Lys Asp Val Phe Ala Phe Gly Gly Ala Val Glu Asn Pro Glu 
    530                 535                 540                 


Tyr Leu Thr Pro Gln Gly Gly Ala Ala Pro Gln Pro His Pro Pro Pro 
545                 550                 555                 560 


Ala Phe Ser Pro Ala Phe Asp Asn Leu Tyr Tyr Trp Asp Gln Asp Pro 
                565                 570                 575     


Pro Glu Arg Gly Ala Pro Pro Ser Thr Phe Lys Gly Thr Pro Thr Ala 
            580                 585                 590         


Glu Asn Pro Glu Tyr Leu Gly Leu Asp Val Pro Val 
        595                 600                 


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Tyr Val Met Ala 
1               


